Protecting senior living residents from respiratory viruses means educating the community around them
By
Kimberly Bonvissuto
Sep 11, 2024
When it comes to increasing vaccination rates against respiratory viruses, it’s not only important to educate senior living residents about the value of vaccines; it’s also important to educate their...
Fewer complications at 18 months seen with post-COVID-19 vaccination myocarditis
By
Haymarket Media
Aug 29, 2024
In contrast, post-COVID-19 myocarditis shows outcomes similar to conventional myocarditis.
All participants exceeded twofold increase in spike-specific IgG, with a geometric mean fold risk of 19.5 on day 57.
Preexisting conditions seen in all patients with tachycardia after COVID-19 vaccine
Jan 10, 2024
Reduced heart rate variability was observed in patients with postvaccination postural orthostatic tachycardia syndrome.
COVID-19 vaccination may increase risk for urinary tract symptoms
Aug 01, 2024
A higher proportion of those who received a single dose versus three doses had to urinate five or more times in the night.
‘Misallocation’ of COVID-19 vaccines led to preventable deaths of older adults: study
By
Kimberly Bonvissuto
Apr 16, 2024
Older adults in New York City may have missed out on timely COVID-19 vaccinations — and possibly died — due to a misallocation of resources that allowed younger adults in wealthy neighborhoods to jump...
Medicare drug price negotiations: A game-changer for seniors’ healthcare
By
Luka Yancopoulos
Nov 02, 2023
The relatively recent passage of the Inflation Reduction Act, which among other provisions, allows Medicare to negotiate prescription drug prices, marks a monumental shift in senior healthcare in America.
Senior living providers should follow CDC’s new ‘unified’ recommendations for COVID, flu, RSV
By
Kimberly Bonvissuto
Mar 04, 2024
Senior living providers should follow the updated respiratory virus isolation recommendations issued Friday by the Centers for Disease Control and Prevention, according to provider advocacy organizations.
Business briefs, Nov. 7
By
Kathleen Steele Gaivin
Nov 07, 2023
“No end in sight” for vaccine challenges … DOL offers webinar to help long-term care employers reduce wage violations … FHA proposes changes to reverse mortgage program … Minimum staff proposal...
FDA approves Capvaxive pneumococcal 21-valent conjugate vaccine
Jun 21, 2024
Merck says the vaccine covers serotypes responsible for approximately 84% of invasive pneumococcal disease in adults aged 50 or more years.